載入...
Development and Validation of Nine Deprescribing Algorithms for Patients on Hemodialysis to Decrease Polypharmacy
BACKGROUND: Polypharmacy is ubiquitous in patients on hemodialysis (HD), and increases risk of adverse events, medication interactions, nonadherence, and mortality. Appropriately applied deprescribing can potentially minimize polypharmacy risks. Existing guidelines are unsuitable for nephrology clin...
Na minha lista:
| 發表在: | Can J Kidney Health Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7605037/ https://ncbi.nlm.nih.gov/pubmed/33194213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2054358120968674 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|